Human Health

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative healthcare products.

Humanpharma
HF_infographic_card

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.

pexels-photo-6942000

About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 2045.

lib_org_D3pZd677

Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on.

Image 8 (1)

Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area.

Our_responsibility

Living with inflammatory and fibrotic diseases greatly impacts patients’ lives, both physically and emotionally. These patients guide and inspire us to turn innovative science into life-changing medical breakthroughs.

young-man-schizo

Central nervous system (CNS) diseases, including schizophrenia or Alzheimer’s disease, are a focus of Boehringer Ingelheim discovery research and development.

Retinal Health Landing Page

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases. Visual impairment and blindness have a profound and devastating impact on the lives of the affected person.